Cellesce Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
- Investors
-
1
Cellesce General Information
Description
Provider of biochemical and bioprocess engineering services intended for drug discovery and organ-on-a-chip applications. The company bioprocessing technology, and specializes in the development, scale-up, and manufacture of patient-derived organoids and uses its proprietary bioprocess and bioreactors for the expansion of human-derived normal and cancer PDOs for multiple applications, including drug screening, enabling healthcare professionals to utilize in-line sensors and real-time monitoring to ensure precise culture conditions, improved yield, and control of organoid size and reduced batch to batch, user to user variability and use them in drug efficacy testing.
Contact Information
Website
www.cellesce.comCorporate Office
- 2 The Old Orchard
- Wiltshire
- Malmesbury SN16 9JW
- England, United Kingdom
Corporate Office
- 2 The Old Orchard
- Wiltshire
- Malmesbury SN16 9JW
- England, United Kingdom
Cellesce Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 06-Dec-2022 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jun-2020 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Jun-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 23-Mar-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 12-Nov-2015 | $140K | $140K | Completed | Startup | |
| 1. University Spin-Out | 12-Apr-2013 | Completed | Startup |
Cellesce Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 7,400 | $0.012829 | $15.79 | $15.79 | 1x | $15.79 | 8.49% |
Cellesce Comparisons
Industry
Financing
Details
Cellesce Competitors (6)
One of Cellesce’s 6 competitors is Mogrify, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mogrify | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Ichorbio | Corporation | Wantage, United Kingdom | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| ScheBo Biotech | Corporation | Giessen, Germany |
Cellesce Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cellesce Patents
Cellesce Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024231672-A1 | Apparatus | Inactive | 09-May-2023 | ||
| GB-202306769-D0 | Composition | Inactive | 09-May-2023 | ||
| GB-202208499-D0 | Composition | Inactive | 10-Jun-2022 | ||
| GB-202107891-D0 | Apparatus | Inactive | 02-Jun-2021 | ||
| GB-201902415-D0 | A device | Inactive | 22-Feb-2019 |
Cellesce Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cellesce Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Development Bank of Wales | Growth/Expansion | Minority | ||
| Innovate UK | Government | Minority | ||
| NC3Rs | Government | Minority | ||
| NG Bio (UK) | Venture Capital | Minority | ||
| Tangram Partners (Farnham) | Venture Capital | Minority |
Cellesce FAQs
-
When was Cellesce founded?
Cellesce was founded in 2013.
-
Where is Cellesce headquartered?
Cellesce is headquartered in Malmesbury, United Kingdom.
-
What is the size of Cellesce?
Cellesce has 12 total employees.
-
What industry is Cellesce in?
Cellesce’s primary industry is Drug Discovery.
-
Is Cellesce a private or public company?
Cellesce is a Private company.
-
What is Cellesce’s current revenue?
The current revenue for Cellesce is .
-
How much funding has Cellesce raised over time?
Cellesce has raised $11M.
-
Who are Cellesce’s investors?
Development Bank of Wales, Innovate UK, NC3Rs, NG Bio (UK), and Tangram Partners (Farnham) are 5 of 6 investors who have invested in Cellesce.
-
Who are Cellesce’s competitors?
Mogrify, Ichorbio, Abcam, Ability Pharma, and ScheBo Biotech are some of the 6 competitors of Cellesce.
-
When was Cellesce acquired?
Cellesce was acquired on 06-Dec-2022.
-
Who acquired Cellesce?
Cellesce was acquired by Molecular Devices.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
